SVUIX | VMVAX | SVUIX / VMVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 16 years | 13 years | - |
Gain YTD | 12.852 | 17.355 | 74% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000000 | 3000 | 66,667% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 360M | 30.9B | 1% |
Annual Yield % from dividends | 2.24 | 2.14 | 105% |
Returns for 1 year | 16.49 | 27.09 | 61% |
Returns for 3 years | -25.79 | 13.54 | -190% |
Returns for 5 years | -2.53 | 47.45 | -5% |
Returns for 10 years | -23.04 | 96.84 | -24% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FIIAX | 24.89 | -0.28 | -1.11% |
Fidelity Advisor Mid Cap II A | |||
WAGSX | 12.39 | -0.15 | -1.20% |
Wasatch Global Select Investor | |||
TSGUX | 18.70 | -0.24 | -1.27% |
Morgan Stanley Pathway Sm-Mid Cap Eq | |||
ITHTX | 59.34 | -0.82 | -1.36% |
Hartford Capital Appreciation R5 | |||
JTKAX | 14.17 | -0.23 | -1.60% |
JHancock Global Thematic Opps A |